Filing Flows › Companies › Oppenheimer Holdings › Analysis traps
Oppenheimer Holdings (OPY): analysis traps
Where its figures could mislead a reader, and what to check before taking them at face value · Data: Q3 2026, to Sep 30, 2026, filed Oct 30, 2026; rules v1.1
Oppenheimer Holdings (OPY): 0 rules of 10 triggered on the filings to Sep 30, 2026. 1 to review; 2 with insufficient data; 5 not applicable. Each is a question to verify, with the normal explanation that would produce the same figures.
Check these first
A precise DCF value = the true value To review · confidence high
The DCF's point value is 109.49 a share (price 90.72); 69% of it is the terminal value, a number about years no one has seen. Moving operating margin by ±3 pts alone takes it from 63.08 to 155.90; across every method the research ran the range is -191 to 3,653. The value is a range; the decimals are not information.
Innocent reading: A stable, mature business with a narrow range of outcomes, where the point value is a fair summary.
Every rule
A01 FCF growth = the business improved Not applicable
a financial company: free cash flow after capex is not the measure of its business
A07 Stock compensation added back = no economic cost Not triggered confidence high
Stock compensation is 2.0% of revenue: small enough that adding it back changes little.
The figures and how they are read
| Fiscal year | FY2025 |
| Stock compensation | $32M |
| Revenue | $1.6B |
| SBC / revenue | +2.0% |
| Buybacks | $3M |
| Buybacks / SBC | 0.1 |
| Diluted shares, year before | 11.2M shares |
| Diluted shares | 11.4M shares |
| Diluted shares: change | +1.4% |
SBC / revenue from the cash flow statement's add-back; the diluted weighted share count year over year; buybacks from the financing section
Source: FY2025 (stock compensation, buybacks and the diluted share count, fiscal year)
B02 Receivables growing = future cash is certain Not applicable
a financial company: receivables and DSO are not its working capital
B08 Adjusted profit = economic profit Insufficient data
no reconciliation table read from the releases yet and fewer than three quarters with both an adjusted and a GAAP EPS
C02 Low net debt = no refinancing risk Insufficient data
no debt figure could be read from the balance sheet (the filing may tag it in other lines)
D03 EPS growth = profit growth Not triggered confidence high
EPS fell 75% and net income fell 75% in Q3 2026; the share count rose 1.2%: EPS growth follows profit growth.
The figures and how they are read
| Quarter | Q3 2026 |
| Quarter before | Q3 2025 |
| EPS, year before | $1.90 |
| EPS | $0.47 |
| Net income, year before | $22M |
| Net income | $5M |
| Diluted shares, year before | 11.5M shares |
| Diluted shares | 11.6M shares |
| EPS growth | -75.2% |
| Net income growth | -74.9% |
| Diluted shares: change | +1.2% |
| eps from profit | -$1.42 |
| eps from share count | -$0.01 |
EPS and net income against the same quarter a year earlier; the EPS bridge attributes the change to profit first, then to the share count (the order is fixed and disclosed)
Source: Q3 2026 (net income, diluted shares, EPS) · Q3 2025 (the same quarter a year earlier)
E02 Low P/E at a cyclical peak = undervalued Not applicable
a financial company: J06 reads its cycle instead
E07 A precise DCF value = the true value To review confidence high
The DCF's point value is 109.49 a share (price 90.72); 69% of it is the terminal value, a number about years no one has seen. Moving operating margin by ±3 pts alone takes it from 63.08 to 155.90; across every method the research ran the range is -191 to 3,653. The value is a range; the decimals are not information.
The figures and how they are read
| dcf value | 109.49 |
| price | 90.72 |
| terminal value share | +69.1% |
| swing by input | Operating margin / ±3 pts / 63.08 / 155.9; Revenue growth (each year) / ±5 pts / 92.66 / 129.4; WACC / ±1 pt / 96.94 / 125.9; Tax rate / ±5 pts / 101.21 / 117.78 |
| range all methods | -191.49; 3652.8 |
the DCF's point value against the share of it that is the terminal value and the value at each input moved by one step (growth ±5 pts, WACC ±1 pt, margin ±3 pts …); the range across every method the research ran
Source: 2026-11-08 (valuation research)
What would explain it innocently
- A stable, mature business with a narrow range of outcomes, where the point value is a fair summary
- The inputs that matter most are themselves well known (a regulated return, a long contract)
What to look for in the filing
- Which input you believe differs from the research's and why
- What the price implies for growth (the reverse DCF on the fair-value page)
What would show the trap does not apply
- The DCF's value is robust to the terminal growth and discount rate (the range's low end is still above the price)
- The company's cash flows over the next three years track the DCF's early years
Look again: next filing.
J06 A bank's low P/E and high profit = safe Not applicable
not a bank
J08 A REIT's low net income = the dividend is unsafe Not applicable
not a REIT
What the statuses mean
Triggered: the filings show the pattern; read the normal explanations and the missing evidence before concluding anything. To review: one quarter or a weak signal; a reader's judgement, not a pattern. Not triggered: the pattern is absent on these figures. Insufficient data: the filings read so far do not hold what the rule needs; this is not a clean bill. Not applicable: the rule is not meant for this kind of company (a bank's working capital, a loss-making quarter's EPS growth). Out of date: the latest filing is more than fifteen months old.
Severity is what the pattern could mean for cash, value or solvency; confidence is how reliable the inputs and the reading are. The two are kept apart.
Record a view
A reader's judgement, grounds, what would change it and the next review; kept in the browser (needs JavaScript).
Every rule and the companies it triggers on → Oppenheimer Holdings: cash flow →
Each rule reads the company's own filings by a fixed formula and says what would explain the same figures innocently. A triggered rule is a question to verify, not a finding of manipulation, and not a view on the stock. Missing data is shown as missing, never as clear. Not investment advice.